Annual ROE
-94.92%
-47.76%-101.27%
December 31, 2023
Summary
- As of February 8, 2025, ATNM annual return on equity is -94.92%, with the most recent change of -47.76% (-101.27%) on December 31, 2023.
- During the last 3 years, ATNM annual ROE has fallen by -58.69% (-161.99%).
- ATNM annual ROE is now -107.39% below its all-time high of 1284.14%, reached on December 31, 2014.
Performance
ATNM ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-100.85%
+0.84%+0.83%
September 30, 2024
Summary
- As of February 8, 2025, ATNM quarterly return on equity is -100.85%, with the most recent change of +0.84% (+0.83%) on September 30, 2024.
- Over the past year, ATNM quarterly ROE has dropped by -5.77% (-6.07%).
- ATNM quarterly ROE is now -108.35% below its all-time high of 1207.88%, reached on September 30, 2014.
Performance
ATNM Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ATNM ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -101.3% | -6.1% |
| 3 y3 years | -162.0% | -219.0% |
| 5 y5 years | +64.6% | +57.5% |
ATNM ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -158.4% | at low | -206.8% | +4.0% |
| 5 y | 5-year | -162.0% | +75.5% | -219.0% | +60.5% |
| alltime | all time | -107.4% | +87.0% | -108.3% | +98.0% |
Actinium Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -100.85%(-0.8%) |
| Jun 2024 | - | -101.69%(-3.2%) |
| Mar 2024 | - | -105.04%(+10.5%) |
| Dec 2023 | -94.92%(+101.3%) | -95.08%(+10.6%) |
| Sep 2023 | - | -85.97%(+21.0%) |
| Jun 2023 | - | -71.03%(+24.8%) |
| Mar 2023 | - | -56.91%(+23.5%) |
| Dec 2022 | -47.16%(+28.4%) | -46.07%(+12.9%) |
| Sep 2022 | - | -40.82%(+13.9%) |
| Jun 2022 | - | -35.83%(+9.0%) |
| Mar 2022 | - | -32.87%(-2.8%) |
| Dec 2021 | -36.74%(+1.4%) | -33.81%(+7.0%) |
| Sep 2021 | - | -31.61%(-8.4%) |
| Jun 2021 | - | -34.52%(-9.9%) |
| Mar 2021 | - | -38.32%(-30.8%) |
| Dec 2020 | -36.23%(-90.7%) | -55.35%(-29.0%) |
| Sep 2020 | - | -77.96%(-37.1%) |
| Jun 2020 | - | -123.95%(-51.5%) |
| Mar 2020 | - | -255.38%(+6.8%) |
| Dec 2019 | -388.02%(+44.6%) | -239.18%(+0.8%) |
| Sep 2019 | - | -237.39%(+6.2%) |
| Jun 2019 | - | -223.62%(+4.6%) |
| Mar 2019 | - | -213.69%(+34.3%) |
| Dec 2018 | -268.41%(+37.9%) | -159.13%(+13.7%) |
| Sep 2018 | - | -139.92%(+9.4%) |
| Jun 2018 | - | -127.86%(-19.7%) |
| Mar 2018 | - | -159.17%(-19.8%) |
| Dec 2017 | -194.58%(+44.1%) | -198.48%(+2.2%) |
| Sep 2017 | - | -194.21%(-7.7%) |
| Jun 2017 | - | -210.49%(+20.7%) |
| Mar 2017 | - | -174.33%(+27.9%) |
| Dec 2016 | -135.06%(+41.2%) | -136.29%(+6.2%) |
| Sep 2016 | - | -128.29%(+25.2%) |
| Jun 2016 | - | -102.44%(+1.1%) |
| Mar 2016 | - | -101.37%(+2.0%) |
| Dec 2015 | -95.68% | -99.42%(-24.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | -131.22%(-40.2%) |
| Jun 2015 | - | -219.47%(+5.3%) |
| Mar 2015 | - | -208.50%(-118.3%) |
| Dec 2014 | 1284.14%(+85.9%) | 1136.53%(-5.9%) |
| Sep 2014 | - | 1207.88%(+48.8%) |
| Jun 2014 | - | 811.83%(-5.2%) |
| Mar 2014 | - | 856.52%(-130.0%) |
| Dec 2013 | 690.85%(-194.7%) | -2853.02%(+286.9%) |
| Sep 2013 | - | -737.38%(-30.9%) |
| Jun 2013 | - | -1067.81%(-51.1%) |
| Mar 2013 | - | -2182.53%(-44.7%) |
| Dec 2012 | -729.85%(+110.2%) | -3947.27%(-23.4%) |
| Sep 2012 | - | -5155.95%(+55.6%) |
| Jun 2012 | - | -3314.36%(+40.6%) |
| Mar 2012 | - | -2357.19%(+25.5%) |
| Dec 2011 | -347.26%(>+9900.0%) | -1878.50%(>+9900.0%) |
| Sep 2011 | - | -5.10%(-368.4%) |
| Jun 2011 | - | 1.90%(-128.1%) |
| Mar 2011 | - | -6.75%(+259.0%) |
| Dec 2010 | -1.80%(-107.8%) | -1.88%(+144.2%) |
| Sep 2010 | - | -0.77%(-89.4%) |
| Jun 2010 | - | -7.25%(-126.5%) |
| Mar 2010 | - | 27.31%(+5.7%) |
| Dec 2009 | 23.16%(-45.1%) | 25.83%(+2.3%) |
| Sep 2009 | - | 25.26%(-4.0%) |
| Jun 2009 | - | 26.31%(-27.7%) |
| Mar 2009 | - | 36.38%(-25.1%) |
| Dec 2008 | 42.16%(-25.9%) | 48.60%(-27.3%) |
| Sep 2008 | - | 66.87%(-23.0%) |
| Jun 2008 | - | 86.90%(-8.0%) |
| Mar 2008 | - | 94.42%(+21.1%) |
| Dec 2007 | 56.91%(-43.1%) | 77.97%(-3.3%) |
| Sep 2007 | - | 80.64%(-25.6%) |
| Jun 2007 | - | 108.37%(+7.2%) |
| Mar 2007 | - | 101.09%(+2.2%) |
| Dec 2006 | 100.00% | 98.91% |
FAQ
- What is Actinium Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals annual ROE year-on-year change?
- What is Actinium Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals quarterly ROE year-on-year change?
What is Actinium Pharmaceuticals annual return on equity?
The current annual ROE of ATNM is -94.92%
What is the all time high annual ROE for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high annual return on equity is 1284.14%
What is Actinium Pharmaceuticals annual ROE year-on-year change?
Over the past year, ATNM annual return on equity has changed by -47.76% (-101.27%)
What is Actinium Pharmaceuticals quarterly return on equity?
The current quarterly ROE of ATNM is -100.85%
What is the all time high quarterly ROE for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high quarterly return on equity is 1207.88%
What is Actinium Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, ATNM quarterly return on equity has changed by -5.77% (-6.07%)